History

PROJECT OVERVIEW

PROJECT DETAILS
  • Category About Us

Aquila Bioscience was founded in 2012 at the National University of Ireland, Galway, by Lokesh Joshi, Stokes Professor of Glycoscience. Through utilising an innovative and revolutionary decontamination technology, Aquila Bioscience offers products that protect individuals against harmful pathogens and biotoxins.

  • 2012

    Founded by Lokesh Joshi in the National University of Ireland, Galway (NUIG)

  • 2013

    European Union Project PATHSENSE for bacterial detection in water
  • 2015

    European Defence Agency Project DCLAW for Biothreat Agent Capture
  • 2016-2020

    Partnerships in PATHSENSE and DCLAW on pathogens
  • 2017

    European Union SME-Phase 1 award to develop Glyco-DeCon technology
  • 2018-19

    Develop Pathogen Capture Technology (PCT)

    IP Filing

  • 2020

    Selected for EU-EIC-Accelerator Award

    Manufacture and deliver its Anti-BioAgent Device (ABD) to 1st responder agencies during COVID-19

    US FDA Class I MedDevice Registration

  • 2021

    Continue to support 1st responder communities with ABD and launch ProShield Mask Spray

  • 2022

    Further develop and diversify PCT for applications beyond security and defence

  • 2023-24

    Commercial partnerships

    Develop PathCap Swabs and Filters

  • 2024-25

    Commercial partnerships and end-user trials

  • 2025-26

    ESA Discovery Programme

RELATED PROJECTS

Copyright © 2025 Aquila Bioscience. All rights reserved.